Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Compound VIII. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111471003B details a cost-effective Negishi coupling route for sitagliptin intermediates, offering high purity and scalable manufacturing solutions.